Latest filing published 12 Oct 2020 for Silence Therapeutics plc, €5,498.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David Lemus: trading record in brief
All filings by David Lemus on record concern Silence Therapeutics plc. In total, 2 filings cover trades dated from 4 October 2019 to 9 October 2020.
Purchases make up the whole of the open-market record (2 purchases, €14k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2020: 1 purchase and no sales on the market.
The newest entry dates from 12 October 2020: an open-market purchase of €5,498, in Silence Therapeutics plc. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to David Lemus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,250 shares@ £4.0039.4% of flowLondon Stock Exchange, AIMISIN GB00B9GTXM62FCA-NSM:3745650-1Canonical exit: 7 Jan 2021 (T+90)
- 4,000 shares@ £1.86100.0% of flowExercise - Outside a trading venue Purchase - London Stock Exchange, AIMISIN GB00B9GTXM62FCA-NSM:LSE20191004172101_14255305_20200326185155804_31146Canonical exit: 2 Jan 2020 (T+90)
2 of 2 declarations